{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T19:24:42Z","timestamp":1648581882364},"reference-count":7,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Urologe"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1007\/s00120-010-2396-3","type":"journal-article","created":{"date-parts":[[2010,10,13]],"date-time":"2010-10-13T12:04:53Z","timestamp":1286971493000},"page":"1274-1276","source":"Crossref","is-referenced-by-count":1,"title":["Nichtmuskelinvasives Urothelkarzinom"],"prefix":"10.1007","volume":"49","author":[{"given":"F.","family":"vom Dorp","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Tschirdewahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"R\u00fcbben","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Jocham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,10,13]]},"reference":[{"key":"2396_CR1","first-page":"665","volume":"37","author":"RUTT","year":"1985","unstructured":"RUTT (Registry of Urinary Tract Tumors) (1985) Essener Harnwegstumorregister: Jahresbericht. Verh Dtsch Ges Urol 37:665","journal-title":"Verh Dtsch Ges Urol"},{"key":"2396_CR2","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1016\/S0022-5347(05)64273-5","volume":"168","author":"Sylvester","year":"2002","unstructured":"Sylvester RJ, Adrian PM, Meijden M van der, Lamm D (2002) Intravesical bacillus clmette guerin reduces the risk of progression in patients with superficial bladder cancer: a meta analysis of the published results of randomized trials. J Urol 168:1964\u20131970","journal-title":"J Urol"},{"key":"2396_CR3","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/01.ju.0000162059.64886.1c","volume":"174","author":"Sylvester","year":"2005","unstructured":"Sylvester RJ, Meijden APM van der, Witjes A, Kurth K (2005) Bacillus calmette Guerin versus chemotherapy for the intravesical treatment of patients with carcinoma in situ of the bladder: a meta-analysis of the published results of randomized clinical trials. J Urol 174:86\u201392","journal-title":"J Urol"},{"key":"2396_CR4","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.eururo.2008.06.062","volume":"54","author":"Herr","year":"2008","unstructured":"Herr HW (2008) Is maintenance Bacillus Calmette Guerin really necessary? Eur Urol 54:971\u2013973","journal-title":"Eur Urol"},{"key":"2396_CR5","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.eururo.2009.04.038","volume":"56","author":"Malmstr\u00f6m","year":"2009","unstructured":"Malmstr\u00f6m PU, Sylvester RJ, Crawford DE et al (2009) An individual patient data mata-analysis of the long-term outcome of randomised studies comparing intravesical mitomycin C versus bacillus calmette Guerin for non-muscle invasive bladder cancer. Eur Urol 56:247\u2013256","journal-title":"Eur Urol"},{"key":"2396_CR6","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.eururo.2009.11.023","volume":"57","author":"Gontero","year":"2010","unstructured":"Gontero P, B\u00f6hle A, Malmstr\u00f6m PU et al (2010) The role of bacillus calmette-guerin in the treatment of non-muscle-invasive bladder cancer. Eur Urol 57:410\u2013429","journal-title":"Eur Urol"},{"key":"2396_CR7","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.eururo.2009.12.024","volume":"57","author":"Sylvester","year":"2010","unstructured":"Sylvester RJ, Brausi MA, Kirkels WJ et al (2010) Long-term efficacy results of EORTC genito-urinary group randomized phase 3 study 30911 comparing intravesical instillations of epirubicin, bacillus Calmette-Gu\u00e9rin, and bacillus Calmette-Gu\u00e9rin plus isoniazid in patients with intermediate- and high-risk stage Ta T1 urothelial carcinoma of the bladder. Eur Urol 57:766\u2013773","journal-title":"Eur Urol"}],"container-title":["Der Urologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-010-2396-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00120-010-2396-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-010-2396-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T11:48:12Z","timestamp":1558612092000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00120-010-2396-3"}},"subtitle":["Ist die Anwendung von BCG noch notwendig?"],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":7,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["2396"],"URL":"https:\/\/doi.org\/10.1007\/s00120-010-2396-3","relation":{},"ISSN":["0340-2592","1433-0563"],"issn-type":[{"value":"0340-2592","type":"print"},{"value":"1433-0563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10]]}}}